In a review published in 1983, an attempt was made to highlight the rheumatological aspects of diseases generally regarded as haematological in origin.' Since then, a variety of reports have served to strengthen the links between these two areas of medicine. In this review, we consider these more recent reports and focus on patient presentation, advances in treatment, and knowledge of underlying mechanisms. Epidemiological data are reviewed and, in particular, we speculate on the possible immunological mechanisms common to lymphoproliferative malignancy and autoimmune disease.
Haemoglobinopathies and iron storage disease SICKLE CELL DISEASE Homozygous (SS) sickle cell disease, heterozygous (SC) sickle cell disease, and the overlap sickle S/( thalassaemia cause major morbidity and mortality. Sickle haemoglobin polymerises when deoxygenated and red cells distort and block small vessels but, nevertheless, the sickle cell gene persists by conferring to heterozygotes resistance against malarial infection.
Sickle cell disease typically presents in childhood with haemolytic anaemia and intermittent crises, during which acute phase reactants such as C reactive protein are increased2 and it is important to achieve pain control, using opioids and possibly intravenous methylprednisolone.3 Severe oligo-or polyarthralgia may develop and transient joint swelling lasting for up to three weeks may occur. 4 The joints feel warm and tender, and septic arthritis, acute gout, and haemarthrosis should be excluded. Joint aspirate is typically yellow, non-inflammatory, sterile, and free of urate crystals. Ankle arthritis is occasionally associated with vaso-occlusive leg ulceration, implying that joint effusion is secondary to synovial and bone ischaemia or infarction. 4 Osteonecrosis contributes significantly to the disabling skeletal manifestations of sickle cell disease and by 2 Bone'0 and magnetic resonance" scanning are sensitive early methods of detecting necrosis, particularly of the spine and pelvis, as nearly 25% of radiographs may be normal at presentation.'2 In the hip, sclerosis and patchy lucency are seen, and the femoral head subsequently flattens and collapses. Treatment requires bed rest initially, and surgery ranges from osteotomy and arthrodesis to various forms of arthroplasty. However, most approaches have met with little success, and replacement surgery is often required. Postoperative complications include haematological crisis,9 infection, loosening of the prosthesis, and fractures at the level of the femoral stem.'3 14 Revision may be necessary,8
and a mean survival of 5-4 years has been estimated for replacement arthroplasty.14 Polyarticular chondrolysis has been reported in a patient who required bilateral hip arthroplasties.'5 Light microscopy showed eroded cartilage with congested vessels and mononuclear cells in the synovium. Electron microscopy found occluded synovial blood vessels, Figure 1 Sickle cell disease. Avascular necrosis, resulting in collapse and sclerotic appearance of the femoral head. Fissuring of the subcortical bone is also evident. Heterozygous thalassaemia (minor) remains a common and usually silent disorder. In a blind study comparing 80 cases of thalassaemia minor with control patients, 55% of cases had musculoskeletal symptoms compared with 54% of controls.32 Arthralgia of the wrist and shoulders was most common, and three patients had a short lived arthritis. In consequence, the authors concluded that no specific form of chronic arthritis occurs.
HEREDITARY (PRIMARY) HAEMOCHROMATOSIS
In the classical inherited form, increased intestinal iron absorption results in excess iron deposition throughout the body. The liver, pancreas, and heart are commonly affected33 with fibrosis and subsequent organ malfunction, and the diagnosis is made by blood tests showing characteristic iron studies and liver biopsy specimens demonstrating iron deposition.34
Haemochromatosis is five to 10 times more frequent in males than females, and 70% of patients develop their first symptoms in middle age.35 An association has been described with the HLA-A3 which is found in 70% of patients (compared with 28% of the general population), and the mode of inheritance is usually autosomal recessive. 36 Arthritis occurs in about 50% of cases34 and is most severe in those over 50 years of age. Both acute and chronic arthropathies are well described and the manifestations are diverse. Acute episodic synovitis, especially in the knees and wrists, is probably the result of calcium pyrophosphate dihydrate deposition, which is found in 67% of patients. The mechanism by which joint tissues respond to intra-articular blood is not fully understood. Animal experiments suggest that, initially, intra-articular bleeding stimulates a non-specific inflammatory response.84 Macrophages accumulate around synovial iron deposits and collagenases and prostaglandins are released by the synovium, which proliferates with repeated bleeding episodes and eventually forms pannus.
The treatment of haemophilic arthritis is based on early efforts to limit the effect of chronic synovitis. Acute haemarthrosis should be treated by bed rest, elevation of the affected limb, ice packs, and the prompt use of clotting factor concentrates, which remains paramount. The early use of clotting factor concentrates delays the onset of haemophilic arthritis, which is directly related to the frequency of joint bleeding, and the current opinion is that treatment with dose regimens of greater than 1000 U/kg/yr is likely to confer protection against progression of arthropathy.82 Approximately 15% of patients develop inhibitor antibodies against factor VIII/IX85 and their treatment has become a major challenge. Porcine FVIII86 and factor VIII bypassing agents such as recombinant activated factor VII87 are treatment modalities with reported success.
Unfortunately, in the past 10 years, the major impact on haemophilia has been infection with HIV-1 virus. This is responsible for considerable morbidity and early death in severe haemophiliacs. In particular, before HIV infection, septic arthritis was rare, estimated to occur in fewer than 0 15% of patients. 109 111 Although the mechanism behind this link between RA and lymphoma is unknown, it seems to relate more to the duration of disease than to its severity, and there is little evidence to support either a common genetic linkage or an environmental factor. Natural killer cell activity is believed to have a role in immune surveillance against malignancy,"2 and is reduced in the blood and synovial tissue of patients with RA"3 and SLE;1"4 however, this would predispose not only to lymphoma but also to 
